These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38142082)

  • 41. Mitochondrial ROS induced by ML385, an Nrf2 inhibitor aggravates the ferroptosis induced by RSL3 in human lung epithelial BEAS-2B cells.
    Taufani IP; Situmorang JH; Febriansah R; Tasminatun S; Sunarno S; Yang LY; Chiang YT; Huang CY
    Hum Exp Toxicol; 2023; 42():9603271221149663. PubMed ID: 36625148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoreactor activated in situ for starvation-chemodynamic therapy of breast cancer.
    Gao L; Xuan X; Sui M; Wang J; Wang Y; Zhang H
    J Drug Target; 2022 Aug; 30(7):767-776. PubMed ID: 35379059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The calcium silicate/alginate composite: preparation and evaluation of its behavior as bioactive injectable hydrogels.
    Han Y; Zeng Q; Li H; Chang J
    Acta Biomater; 2013 Nov; 9(11):9107-17. PubMed ID: 23796407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Luminol-Based Self-Illuminating Nanocage as a Reactive Oxygen Species Amplifier to Enhance Deep Tumor Penetration and Synergistic Therapy.
    Xu XL; Zhang NN; Shu GF; Liu D; Qi J; Jin FY; Ji JS; Du YZ
    ACS Nano; 2021 Dec; 15(12):19394-19408. PubMed ID: 34806870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells.
    Peng S; Chen G; Yu KN; Feng Y; Zhao L; Yang M; Cao W; Almahi WAA; Sun M; Xu Y; Zhao Y; Cheng C; Zhu F; Han W
    Cell Commun Signal; 2024 Feb; 22(1):112. PubMed ID: 38347507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shikonin Could Be Used to Treat Tubal Pregnancy via Enhancing Ferroptosis Sensitivity.
    Lai Y; Zeng F; Chen Z; Feng M; Huang Y; Qiu P; Zeng L; Ke Y; Deng G; Gao J
    Drug Des Devel Ther; 2022; 16():2083-2099. PubMed ID: 35800255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fe-MnO
    Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
    Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification.
    Feng W; Shi W; Wang Z; Cui Y; Shao X; Liu S; Rong L; Liu Y; Zhang H
    ACS Appl Mater Interfaces; 2022 Aug; 14(33):37540-37552. PubMed ID: 35944147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depriving Tumor Cells of Ways to Metastasize: Ferroptosis Nanotherapy Blocks Both Hematogenous Metastasis and Lymphatic Metastasis.
    Guo R; Deng M; Li J; He X; He P; Liu H; Ye Y; Mo Z; He X; Li M; He Q
    Nano Lett; 2023 Apr; 23(8):3401-3411. PubMed ID: 37036326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.
    Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K
    ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy.
    Liu Y; Qi P; Chen G; Lang Z; Wang J; Wang X
    Biomater Adv; 2024 Feb; 157():213758. PubMed ID: 38199000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
    Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S
    Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis.
    Asperti M; Bellini S; Grillo E; Gryzik M; Cantamessa L; Ronca R; Maccarinelli F; Salvi A; De Petro G; Arosio P; Mitola S; Poli M
    Free Radic Biol Med; 2021 Jun; 169():294-303. PubMed ID: 33892112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
    Probst L; Dächert J; Schenk B; Fulda S
    Biochem Pharmacol; 2017 Sep; 140():41-52. PubMed ID: 28595877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MoS
    Zhou L; Zhao J; Chen Y; Zheng Y; Li J; Zhao J; Zhang J; Liu Y; Liu X; Wang S
    Colloids Surf B Biointerfaces; 2020 Nov; 195():111243. PubMed ID: 32663712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fe
    Chen L; Lin Z; Liu L; Zhang X; Shi W; Ge D; Sun Y
    ACS Biomater Sci Eng; 2019 Sep; 5(9):4861-4869. PubMed ID: 33448829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Berberine protects cardiac cells against ferroptosis.
    Yang KT; Chao TH; Wang IC; Luo YP; Ting PC; Lin JH; Chang JC
    Tzu Chi Med J; 2022; 34(3):310-317. PubMed ID: 35912047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy.
    Li J; Zhou Y; Liu J; Yang X; Zhang K; Lei L; Hu H; Zhang H; Ouyang L; Gao H
    J Control Release; 2022 Dec; 352():313-327. PubMed ID: 36272661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress in the Mechanism of the Effect of Fe
    Wang Y; Wu X; Bao X; Mou X
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.